Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

August 26, 2015 - 5:01 p.m.
Results From the AMBITION Study of First-Line Treatment With Letairis and Tadalafil in Pulmonary Arterial Hypertension Published in The New England Journal of MedicinePrinter Friendly Version 
August 20, 2015 - 4:32 p.m.
European Medicines Agency Validates Gilead’s Marketing Application for Single Tablet Regimen Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF) for HIV TreatmentPrinter Friendly Version 

Upcoming Events

Thursday, September 17, 2015 through Monday, September 21, 2015
55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
LocationSan Diego, CA

Most Viewed Links

Updated 08/15/15
2.SEC Filings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 08/07/15 - 08/14/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 0.21 (0.19%)
Data as of 08/28/15 4:15 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Second Quarter 2015 Gilead Sciences Earnings Conference Call

July 28, 2015 4:30 p.m. ET
Goldman Sachs 36th Annual Global Healthcare Conference

June 09, 2015 10:00 a.m. PT